The Recall Desk
ModerateFDA (Devices)·Z-1378-2014·Announced 2014-04-16

LumiQuick MDMA/Ecstasy Strip Recalled for Unauthorized Distribution

LumiQuick Diagnostics is recalling MDMA/Ecstasy test strips because they were shipped to locations without required FDA regulatory clearance.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or specific health hazards, indicating a regulatory compliance issue rather than a direct safety threat.

Plain-English summary

LumiQuick Diagnostics Inc. is recalling all lots of the MDMA/Ecstasy Strip (Catalog number 74023). The recall was initiated because the products were shipped to US locations that do not have approved applications for Premarket Approval (PMA), Investigational Device Exemption (IDE), or 510(k) clearance.

The affected products were distributed in the states of California, Florida, New Jersey, Texas, and New York. The recall covers all lots of the product.

Consumers who have purchased these test strips should stop using them and contact the manufacturer for further instructions.

The recalled product

Product
MDMA/Ecstasy Strip; LumiQuick. Santa Clara, CA 95054

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Catalog number: 74023
  • All lots

Distribution

Distributed in 5 states:

Part of a larger recall action

This product is one of 80 recalled by LumiQuick Diagnostics Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 80 products in this recall →

Same manufacturer · LumiQuick Diagnostics Inc.

See all →